Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Alliance Pharma PLC - Chippenham, England-based distributor of consumer healthcare brands and prescription medicines - Confirms that it is in talks with an unnamed third party for the acquisition of two products in the US. Should an acquisition take place the aggregate payment would come up to $20 million at the most.
Current stock price: 111.80 pence
12-month change: up 32%
Copyright 2022 Alliance News Limited. All Rights Reserved.